Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
miglustat (zavesca) (1 trial)
azithromycin (zithromax) (1 trial)
bismuth (1 trial)
omeprazole (prilosec) (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
Fatty Liver (Phase 2)
Gangliosidoses (Phase 3)
Gangliosidoses, GM2 (Phase 3)
Liver Diseases (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Tay-Sachs Disease (Phase 3)
Trials (2 total)
Trial APIs (5 total)